vs
Side-by-side financial comparison of BLACKLINE, INC. (BL) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $183.2M, roughly 1.6× BLACKLINE, INC.). Bio-Techne runs the higher net margin — 12.8% vs 2.7%, a 10.2% gap on every dollar of revenue. On growth, BLACKLINE, INC. posted the faster year-over-year revenue change (8.1% vs -6.4%). Over the past eight quarters, BLACKLINE, INC.'s revenue compounded faster (7.9% CAGR vs 4.2%).
BlackLine Systems, Inc., is an American enterprise software company that develops cloud-based services designed to automate and manage the entire financial close process as well as consolidation, invoice-to-cash, and intercompany accounting. The Los Angeles–based company has 17 offices worldwide.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
BL vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $183.2M | $295.9M |
| Net Profit | $4.9M | $38.0M |
| Gross Margin | 75.2% | 64.6% |
| Operating Margin | 3.7% | 18.4% |
| Net Margin | 2.7% | 12.8% |
| Revenue YoY | 8.1% | -6.4% |
| Net Profit YoY | -91.3% | 68.3% |
| EPS (diluted) | $0.07 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $183.2M | $295.9M | ||
| Q3 25 | $178.3M | — | ||
| Q2 25 | $172.0M | $317.0M | ||
| Q1 25 | $166.9M | $316.2M | ||
| Q4 24 | $169.5M | $297.0M | ||
| Q3 24 | $165.9M | $289.5M | ||
| Q2 24 | $160.5M | $306.1M | ||
| Q1 24 | $157.5M | $303.4M |
| Q4 25 | $4.9M | $38.0M | ||
| Q3 25 | $5.3M | — | ||
| Q2 25 | $8.3M | $-17.7M | ||
| Q1 25 | $6.1M | $22.6M | ||
| Q4 24 | $56.4M | $34.9M | ||
| Q3 24 | $17.2M | $33.6M | ||
| Q2 24 | $76.7M | $40.6M | ||
| Q1 24 | $10.8M | $49.1M |
| Q4 25 | 75.2% | 64.6% | ||
| Q3 25 | 75.1% | — | ||
| Q2 25 | 75.2% | 62.7% | ||
| Q1 25 | 75.5% | 67.9% | ||
| Q4 24 | 75.6% | 65.3% | ||
| Q3 24 | 75.2% | 63.2% | ||
| Q2 24 | 74.9% | 66.4% | ||
| Q1 24 | 75.2% | 67.4% |
| Q4 25 | 3.7% | 18.4% | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | 4.4% | -7.5% | ||
| Q1 25 | 2.1% | 12.2% | ||
| Q4 24 | 3.7% | 16.0% | ||
| Q3 24 | 5.0% | 13.8% | ||
| Q2 24 | 1.4% | 15.0% | ||
| Q1 24 | 1.1% | 22.1% |
| Q4 25 | 2.7% | 12.8% | ||
| Q3 25 | 3.0% | — | ||
| Q2 25 | 4.8% | -5.6% | ||
| Q1 25 | 3.6% | 7.1% | ||
| Q4 24 | 33.3% | 11.7% | ||
| Q3 24 | 10.4% | 11.6% | ||
| Q2 24 | 47.8% | 13.3% | ||
| Q1 24 | 6.9% | 16.2% |
| Q4 25 | $0.07 | $0.24 | ||
| Q3 25 | $0.09 | — | ||
| Q2 25 | $0.13 | $-0.11 | ||
| Q1 25 | $0.10 | $0.14 | ||
| Q4 24 | $0.79 | $0.22 | ||
| Q3 24 | $0.27 | $0.21 | ||
| Q2 24 | $0.22 | $0.26 | ||
| Q1 24 | $0.17 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $390.0M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $332.3M | $2.0B |
| Total Assets | $1.8B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $390.0M | $172.9M | ||
| Q3 25 | $419.9M | — | ||
| Q2 25 | $459.1M | $162.2M | ||
| Q1 25 | $479.5M | $140.7M | ||
| Q4 24 | $885.9M | $177.5M | ||
| Q3 24 | $725.3M | $187.5M | ||
| Q2 24 | $616.6M | $152.9M | ||
| Q1 24 | $331.4M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $332.3M | $2.0B | ||
| Q3 25 | $328.3M | — | ||
| Q2 25 | $414.0M | $1.9B | ||
| Q1 25 | $417.9M | $2.0B | ||
| Q4 24 | $446.7M | $2.1B | ||
| Q3 24 | $367.9M | $2.1B | ||
| Q2 24 | $325.8M | $2.1B | ||
| Q1 24 | $279.8M | $2.0B |
| Q4 25 | $1.8B | $2.5B | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.8B | $2.6B | ||
| Q1 25 | $1.8B | $2.6B | ||
| Q4 24 | $1.8B | $2.7B | ||
| Q3 24 | $1.7B | $2.7B | ||
| Q2 24 | $1.9B | $2.7B | ||
| Q1 24 | $2.1B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.7M | — |
| Free Cash FlowOCF − Capex | $26.1M | — |
| FCF MarginFCF / Revenue | 14.2% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 5.46× | — |
| TTM Free Cash FlowTrailing 4 quarters | $161.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.7M | — | ||
| Q3 25 | $63.8M | — | ||
| Q2 25 | $32.3M | $98.2M | ||
| Q1 25 | $46.7M | $41.1M | ||
| Q4 24 | $43.8M | $84.3M | ||
| Q3 24 | $55.9M | $63.9M | ||
| Q2 24 | $40.7M | $75.5M | ||
| Q1 24 | $50.4M | $81.0M |
| Q4 25 | $26.1M | — | ||
| Q3 25 | $63.3M | — | ||
| Q2 25 | $31.4M | $93.3M | ||
| Q1 25 | $40.8M | $31.0M | ||
| Q4 24 | $43.0M | $77.5M | ||
| Q3 24 | $55.5M | $54.7M | ||
| Q2 24 | $40.0M | $57.5M | ||
| Q1 24 | $50.1M | $64.5M |
| Q4 25 | 14.2% | — | ||
| Q3 25 | 35.5% | — | ||
| Q2 25 | 18.2% | 29.4% | ||
| Q1 25 | 24.4% | 9.8% | ||
| Q4 24 | 25.4% | 26.1% | ||
| Q3 24 | 33.5% | 18.9% | ||
| Q2 24 | 24.9% | 18.8% | ||
| Q1 24 | 31.8% | 21.3% |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.6% | 1.5% | ||
| Q1 25 | 3.6% | 3.2% | ||
| Q4 24 | 0.4% | 2.3% | ||
| Q3 24 | 0.2% | 3.2% | ||
| Q2 24 | 0.4% | 5.9% | ||
| Q1 24 | 0.2% | 5.4% |
| Q4 25 | 5.46× | — | ||
| Q3 25 | 12.07× | — | ||
| Q2 25 | 3.90× | — | ||
| Q1 25 | 7.72× | 1.82× | ||
| Q4 24 | 0.78× | 2.42× | ||
| Q3 24 | 3.24× | 1.90× | ||
| Q2 24 | 0.53× | 1.86× | ||
| Q1 24 | 4.66× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BL
| Subscription And Circulation | $173.2M | 95% |
| Technology Service | $10.0M | 5% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
